Investment Case Summary
- EBITDA jumped 178% to A$1.75m on just 16% revenue growth, showing genuine operating leverage.
- ARR now covers 82% of total revenue and is growing faster than the headline top line.
- Cash more than doubled to A$3.08m with no capital raise, funding future growth internally.
Recurring revenue now covers 82% of the top line and the cash balance more than doubled
Jcurve Solutions (ASX:JCS) delivered a preliminary unaudited FY26 result that quietly ticks nearly every box small-cap SaaS investors look for. Revenue landed at A$13.28 million, up 16.3% on FY25, and hit the upper end of the guidance range flagged at the Q2 update. That is the easy part of the story.
The harder part is the operating leverage. EBITDA jumped 177.8% to A$1.75 million from A$0.63 million a year earlier, and normalised EBITDA more than doubled to A$1.87 million. Cash at year end came in at A$3.08 million, up from A$1.36 million, funded entirely by operations rather than the market.
Sitting behind those numbers is annual recurring revenue of A$10.84 million, an 18.3% lift, growing faster than total revenue. That mix shift is what actually matters here. The business is compounding recurring dollars faster than one-off services dollars, which is the shape investors want from a NetSuite-anchored ERP reseller trying to earn a genuine SaaS multiple.
Management sounded confident going into FY27 and flagged opportunities to further accelerate ARR growth. The obvious question is what that acceleration costs.
- Updated
- INSIDER CONVICTION TRADES FY26
The market hasn't noticed yet.
Disclosed by law. Missed by most investors. 129 trades tracked by us.
NO Credit card
- Director buys & sells tracked
- Buy / Hold / Sell verdict on every stock
- Technical analysis included
Why the operating leverage matters more than the revenue print
A 16% revenue lift is respectable but not extraordinary for a small-cap technology name. What is extraordinary is turning that 16% top-line growth into a near tripling of EBITDA. That is textbook operating leverage kicking in as fixed costs get spread over a bigger recurring revenue base.
The ratio worth watching is ARR against total revenue. ARR of A$10.84 million against A$13.28 million in total revenue means roughly 82% of the business is now recurring. A year ago that ratio sat at around 80%. Small shift, but the trend is in the right direction and it is the trend that supports a higher multiple over time.
The skeptical read is that a single year of 178% EBITDA growth is easy to celebrate and hard to repeat. We would want to see the next result confirm that the cost base has genuinely stabilised rather than simply lagging the revenue ramp.
The cash balance tells its own story
A$3.08 million in cash is not a war chest, but the direction of travel is what counts. The balance more than doubled year on year without any capital raise, which means the business is now self-funding growth. For a micro-cap that has spent years proving its model works, that shift alone changes the risk profile.
It also means management can be selective about the acceleration opportunities Chris King mentioned in the release. Whether that acceleration comes from bolt-on acquisitions, incremental product investment or a bigger sales team, the company can now fund modest expansion internally rather than issuing paper at what is still a thin small-cap valuation.
What FY27 needs to prove
Management flagged significant momentum into FY27 and hinted at opportunities to accelerate ARR growth. That phrasing does real work. It signals the company is not content to let ARR compound at 18% and is actively looking for ways to lift the rate.
The next data point is the full FY26 investor call scheduled for 30 July. That is where investors will get colour on the pipeline, the customer count, gross margin behaviour and any hints on the shape of any acceleration plan. Guidance for FY27, if offered, will set the frame for the stock through the first half.
The Investors Takeaway for Jcurve Solutions
The FY26 result is the kind of quiet, boring, compounding update that small-cap SaaS investors should like. Recurring revenue growing faster than total revenue, EBITDA growing much faster than recurring revenue, and cash growing faster than EBITDA. That stacking of leverage is what turns a small-cap into something bigger over time, provided nothing breaks.
The risk from here is not the numbers, it is the ambition. Any acceleration strategy that involves acquisitions or a step-change in sales spend will test whether management can preserve the operating leverage that made FY26 look this clean. We would rather see slower but sustained progress than a bolder plan that hands back the margin gains.
Investors can find more in-depth coverage of ASX-listed small-cap software names at stocksdownunder.
